Successful surgical treatment of cardiac metastasis from uterine leiomyosarcoma: A case report and literature review

J Obstet Gynaecol Res. 2020 May;46(5):795-800. doi: 10.1111/jog.14231. Epub 2020 Mar 12.

Abstract

Uterine leiomyosarcoma is a malignant soft tissue tumor resembling uterine fibroma clinically and is difficult to diagnose preoperatively. Since metastatic cardiac tumors are very rare and asymptomatic, most cardiac metastases are detected at autopsy after death due to other diseases. A 49-year-old woman presented with menorrhagia and anemia, and a uterine tumor. Total hysterectomy was performed for the uterine tumor. Histopathological examination revealed the tumor to be a leiomyosarcoma. Postoperative computed tomography showed multiple lung metastases and a metastatic cardiac tumor. The cardiac tumor, which was located within and almost entirely occluded the right ventricle, was 49 × 26 mm. To prevent sudden death, cardiac tumorectomy was performed semi-emergently. Chemotherapy was initiated in the early postoperative period, and the patient currently maintains a complete response. Cases with lung and cardiac metastases rarely undergo surgical resection of metastatic tumors. However, emergent surgical resection of cardiac metastatic tumors should be considered to prevent sudden death.

Keywords: chemotherapy; metastatic cardiac tumor; uterine leiomyosarcoma.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Docetaxel / administration & dosage
  • Female
  • Gemcitabine
  • Heart Neoplasms / diagnosis
  • Heart Neoplasms / pathology*
  • Heart Neoplasms / secondary*
  • Heart Neoplasms / surgery
  • Humans
  • Hysterectomy
  • Leiomyosarcoma / pathology*
  • Leiomyosarcoma / therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / secondary
  • Lung Neoplasms / therapy
  • Middle Aged
  • Uterine Neoplasms / diagnosis
  • Uterine Neoplasms / therapy*

Substances

  • Deoxycytidine
  • Docetaxel
  • Gemcitabine